U.S. Benign Prostatic Hyperplasia Therapeutic Devices Market

 

Regular Price: USD 4,950

Special Price USD 3,465

30% OFF

* Required Fields

Regular Price: USD 4,950

Special Price USD 3,465

PAY BY INVOICE

Be the first to review this product

This research service analyzes the market for benign prostatic hyperplasia therapeutic devices within the United States. The U.S. BPH therapeutic devices market was divided into the RF ablation, microwave thermotherapy, interstitial laser coagulation, and permanent urethral stents market segments. Each segment of this service covers market drivers and restraints, technology and market trends, competitive structure and revenue forecasts. The key challenges and strategies are covered for the total market overview.

Table of Contents

U.S. Benign Prostatic Hyperplasia Therapeutic Devices Market, Executive SummaryIntroductionU.S. Benign Prostatic Hyperplasia Therapeutic Devices MarketU.S. Benign Prostatic Hyperplasia Therapeutic Devices Market, Total U.S. Benign Prostatic Hyperplasia Therapeutic Devices MarketMarket OverviewIntroductionDefinitionsResearch MethodologyScope and SegmentationMarket DynamicsMarket DriversMarket RestraintsMarket Engineering MeasurementsMarket Forecasts and TrendsRevenue ForecastsProcedure ForecastsCompetitive AnalysisCompetitive StructureMarket Share AnalysisProduct AnalysisCompetitive FactorsDistribution StructureEnd-user GroupsIndustry Challenges and RecommendationsIndustry ChallengesStrategic RecommendationsU.S. Benign Prostatic Hyperplasia Therapeutic Devices Market, RF Ablation Devices MarketOverviewMarket OverviewTechnology AnalysisMarket DynamicsMarket DriversMarket RestraintsMarket Engineering MeasurementsMarket Forecasts and TrendsRevenue ForecastsUnit ForecastsCompetitive AnalysisCompetitive StructureMarket Share AnalysisProduct AnalysisU.S. Benign Prostatic Hyperplasia Therapeutic Devices Market, Microwave Thermotherapy Devices MarketOverviewMarket OverviewTechnology AnalysisMarket DynamicsMarket DriversMarket RestraintsMarket Engineering MeasurementsMarket Forecasts and TrendsRevenue ForecastsUnit ForecastsCompetitive AnalysisCompetitive StructureMarket Share AnalysisProduct AnalysisU.S. Benign Prostatic Hyperplasia Therapeutic Devices Market, Interstitial Laser Coagulation Devices MarketOverviewMarket OverviewTechnology AnalysisMarket DynamicsMarket DriversMarket RestraintsMarket Engineering MeasurementsMarket Forecasts and TrendsRevenue ForecastsUnit ForecastsCompetitive AnalysisCompetitive StructureMarket Share AnalysisProduct AnalysisU.S. Benign Prostatic Hyperplasia Therapeutic Devices Market, Permanent Urethral Stents MarketOverviewMarket OverviewTechnology AnalysisMarket DynamicsMarket DriversMarket RestraintsMarket Engineering MeasurementsMarket Forecasts and TrendsRevenue ForecastsUnit ForecastsCompetitive AnalysisCompetitive StructureMarket Share AnalysisProduct AnalysisU.S. Benign Prostatic Hyperplasia Therapeutic Devices Market, AppendixDecision Support DatabaseMale Population 65 and AboveMale PopulationMale Life ExpectancyNumber of HospitalsNumber of Urologists




Keyword1

Keyword2

Keyword3

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.